Neumora Therapeutics, Inc. Common StockNMRANASDAQ
LOADING
|||
EPS Growth Under Pressure
Trending lower, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
-6.06%
↑ 88% above average
Average (19q)
-50.72%
Historical baseline
Range
High:84.62%
Low:-963.64%
Volatility
-2066.6%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -6.06% |
| Q2 2025 | 21.43% |
| Q1 2025 | -13.51% |
| Q4 2024 | 17.78% |
| Q3 2024 | -21.62% |
| Q2 2024 | -8.82% |
| Q1 2024 | 50.00% |
| Q4 2023 | -100.00% |
| Q3 2023 | -36.00% |
| Q2 2023 | -8.70% |
| Q1 2023 | -21.05% |
| Q4 2022 | 0.00% |
| Q3 2022 | 5.00% |
| Q2 2022 | 28.57% |
| Q1 2022 | -55.56% |
| Q4 2021 | 84.62% |
| Q3 2021 | -963.64% |
| Q2 2021 | -10.00% |
| Q1 2021 | 23.08% |
| Q4 2020 | 0.00% |